A-31
Novel Integrated Area Unit
7F
0711B
Innovation of cutting-edge fundamental technologies to accelerate drug discovery and regenerative medicine: Creation of physiologically-relevant cardiac tissues, and Development of system to acquire/evaluate biomedical information
Focusing on drug discovery, biological pacemakers, and organ-like three-dimensional cardiac tissues, we will advance each system/technology development by employing innovative technologies. In addition, we will develop acquisition/evaluation techniques for obtaining and assessing biomedical information for the diagnosis and treatment of arrhythmias and heart failure, aiming to implement them in society.
Responsible Department
Department of Cardiovascular Regenerative Medicine and Drug Discovery
Research Partners
SUZUKEN CO., LTD.
Alpha MED Scientific Inc.
AFI Corporation.
Project Members
Principal Investigator
Specially Appointed Professor
Department of Cardiovascular Regenerative Medicine and Drug Discovery
Members
Specially Appointed Assistant Professor
Department of Cardiovascular Regenerative Medicine and Drug Discovery